The global traumatic brain injury assessment & management devices market size is expected to be worth around US$ 10.5 billion by 2030, according to a new report by Vision Research Reports.
The global traumatic brain injury assessment & management devices market size was valued at US$ 3.9 billion in 2020 and is anticipated to grow at a CAGR of 9.3% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 10.5 Bn by 2030 |
Growth Rate | CAGR of 9.3% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Device, technique, end-use |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | BioDirection, Inc.; BrainScope Company, Inc.; Neural Analytics, Inc.; Compumedics Ltd.; Integra LifeSciences; Natus Medical, Inc. |
Growth Factors
The increasing prevalence of traumatic brain injuries (TBIs), rising patients’ preference for minimally invasive procedures, and rising awareness regarding brain injuries are the major factors expected to fuel the market growth. In addition, the adoption of technologically advanced products and supportive government policies are few more factors contributing to the market growth. Traumatic brain injuries are permanent or temporary impairment to the brain that can be caused by a blow, bump, or shock to the skull. Major causes of TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents.
By Device Analysis
The imaging devices segment dominated the market with a share of 55.04% in 2020. The imaging devices are further segmented into computed tomography (CT), magnetic resonance imaging (MRI) devices, X-ray, and others.
The monitoring devices segment is expected to expand at the highest CAGR of 9.6% from 2021 to 2030 owing to the minimally invasive nature of these devices, increasing awareness, and improvement in healthcare facilities.
By Technique Analysis
The intracranial pressure (ICP) monitoring segment dominated the market with a share of 55.61% in 2020. This method is considered to be a gold standard for the accurate measurement of intracranial pressure in patients with severe brain injury.
The partial pressure of oxygen in the brain tissue (pBrO2) segment is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. Continuous pBrO2 monitoring provides timely information about cerebral oxygen demand in patients suffering from traumatic brain injury.
By End-use Analysis
The hospitals' segment dominated the market with a share of 43.17% in 2020 owing to the increase in the number of brain surgeries performed in hospitals as well as a surge in the prevalence of TBIs patients globally.
The others' segment including ambulatory surgical centers, research centers, and emergency clinics is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. This is attributed to numerous advantages offered by emergency clinics and ASCs such as shorter procedure time and same-day discharge as compared to hospitals.
By Regional Analysis
North America dominated the market with a share of 53.73% in 2020. This is attributed to the presence of well-established healthcare facilities in the region, increasing government initiatives, awareness campaigns regarding brain injuries, and greater incidence of traumatic brain injuries in the region.
The Asia Pacific region is expected to expand at the highest CAGR of 10.9% from 2021 to 2030. This is attributed to factors such as growth in the aging population, rise in the number of people suffering from traumatic brain injuries, increasing incidence of road accidents, and violence.
Key Players
BrainScope Company, Inc.
Neural Analytics, Inc.
Advanced Brain Monitoring Inc.
Natus Medical, Inc.
Integra Lifesciences
BioDirection, Inc.
Nihon Kohden Corporation
Compumedics Ltd.
InfraScan, Inc.
Oculogica
Raumedic AG
Market Segmentation
By Device
Imaging Devices
Magnetic Resonance Imaging (MRI) Devices
X-ray
Computed Tomography
Others
Monitoring Devices
By Technique
Intracranial Pressure (ICP) Monitoring
Partial Pressure of Oxygen in Brain Tissue (pBrO2)
By End-use
Hospitals
Diagnostic Centers
Others
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
The Traumatic Brain Injury Assessment & Management Devices market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Traumatic Brain Injury Assessment & Management Devices market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Traumatic Brain Injury Assessment & Management Devices market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Traumatic Brain Injury Assessment & Management Devices market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Traumatic Brain Injury Assessment & Management Devices market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Traumatic Brain Injury Assessment & Management Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Traumatic Brain Injury Assessment & Management Devices by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Traumatic Brain Injury Assessment & Management Devices market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Traumatic Brain Injury Assessment & Management Devices market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Traumatic Brain Injury Assessment & Management Devices market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Traumatic Brain Injury Assessment & Management Devices industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Traumatic Brain Injury Assessment & Management Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Traumatic Brain Injury Assessment & Management Devices market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Traumatic Brain Injury Assessment & Management Devices market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Traumatic Brain Injury Assessment & Management Devices market. These factors have benefited the growth of the global market for Traumatic Brain Injury Assessment & Management Devices. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Traumatic Brain Injury Assessment & Management Devices. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Traumatic Brain Injury Assessment & Management Devices are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Traumatic Brain Injury Assessment & Management Devices Market, By Device
7.1. Traumatic Brain Injury Assessment & Management Devices Market, by Device, 2021-2030
7.1.1. Imaging Devices
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Monitoring Devices
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Traumatic Brain Injury Assessment & Management Devices Market, By Technique
8.1. Traumatic Brain Injury Assessment & Management Devices Market, by Technique, 2021-2030
8.1.1. Intracranial Pressure (ICP) Monitoring
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Traumatic Brain Injury Assessment & Management Devices Market, By End User
9.1. Traumatic Brain Injury Assessment & Management Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Traumatic Brain Injury Assessment & Management Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. BrainScope Company, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Neural Analytics, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Advanced Brain Monitoring Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Natus Medical, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Integra Lifesciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. BioDirection, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nihon Kohden Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Compumedics Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. InfraScan, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Oculogica
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms